Neuronal migration is transiently delayed by prenatal exposure to intermittent hypoxia

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 74, Issue 4, 2005, Pages 287-299

  Zechel, Jennifer L ^a   Gamboa, Jorge L ^a   Peterson, Allyn G ^a   Puchowicz, Michelle A ^a   Selman, Warren R ^a   Lust, W David ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain development; IH; Neuronal migration; Nicotine

Indexed keywords

ABELSON KINASE; ACTIN; CATALASE; CYCLIN DEPENDENT KINASE 5; F ACTIN; H ACTIN; NICOTINE; PROTEIN P25; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH WEIGHT; BODY WEIGHT; BRAIN DEVELOPMENT; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; FEMALE; HYPOXIA; LONG TERM CARE; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROFILAMENT; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PUERPERIUM; RAT; SMOKING; STATISTICAL SIGNIFICANCE;

ACTINS; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BODY WEIGHT; CATALASE; CELL MOVEMENT; FEMALE; GLUTATHIONE PEROXIDASE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MATERNAL EXPOSURE; NEURONS; NICOTINE; PREGNANCY; PREGNANCY, ANIMAL; PRENATAL EXPOSURE DELAYED EFFECTS; PROTO-ONCOGENE PROTEINS C-ABL; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 24644454814     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20051     Document Type: Article

References (57)

1. Amstad P, Peskin A, Shah G, Mirault ME, Moret R, Zbinden I, Cerutti P. 1991. The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30:9305-9313.
2. Bayer S, Altman J. 1991. Neocortical development. New York: Raven Press.
3. Braaksma MA, Douma BR, Nyakas C, Luiten PG, Aarnoudse JG. 1999. Delayed neuronal migration of protein kinase Cgamma immunoreactive cells in hippocampal CA1 area after 48 h of moderate hypoxemia in the near term ovine fetus. Brain Res Dev Brain Res 114:253-260.
4. Cao C, Leng Y, Kufe D. 2003a. Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem 278:29667-29675.
5. Cao C, Leng Y, Liu X, Yi Y, Li P, Kufe D. 2003b. Catalase is regulated by ubiquitination and proteasomal degradation. Role of the c-Abl and Arg tyrosine kinases. Biochemistry 42:10348-10353.
6. Chen WJ, Kelly RB. 2005. Effect of prenatal or perinatal nicotine exposure on neonatal thyroid status and offspring growth in rats. Life Sci 76:1249-1258.
7. Ernst M, Moolchan ET, Robinson ML. 2001. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40:630-641.
8. Evrard P, Caviness VS Jr, Prats-Vinas J, Lyon G. 1978. The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis bases upon cytoarchitectonic analysis. Acta Neuropathol (Berl) 41:109-117.
9. Fewell JE, Smith FG, Ng VK. 2001. Threshold levels of maternal nicotine impairing protective responses of newborn rats to intermittent hypoxia. J Appl Physiol 90:1968-1976.
10. Flohé L, Günzler WA. 1984. Assays of glutathione peroxidase. Methods Enzymol 105:114-121.
11. Frasca F, Vigneri P, Vella V, Vigneri R, Wang JY. 2001. Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor. Oncogene 20:3845-3856.
12. Fucile S, Renzi M, Lauro C, Limatola C, Ciotti T, Eusebi F. 2004. Nicotinic cholinergic stimulation promotes survival and reduces motility of cultured rat cerebellar granule cells. Neuroscience 127:53-61.
13. Gozal D, Reeves SR, Row BW, Neville JJ, Guo SZ, Lipton AJ. 2003. Respiratory effects of gestational intermittent hypoxia in the developing rat. Am J Respir Crit Care Med 167:1540-1547.
14. Gruslin A, Perkins SL, Manchanda R, Fleming N, Clinch JJ. 2000. Maternal smoking and fetal erythropoietin levels. Obstet Gynecol 95:561-564.
15. Guan ZZ, Yu WF, Nordberg A. 2003. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int 43:243-249.
16. Hermans RH, Longo LD, McGivern RF. 1994. Decreased postnatal testosterone and corticosterone concentrations in rats following acute intermittent prenatal hypoxia without alterations in adult male sex behavior. Neurotoxicol Teratol 16:201-206.
17. Jongen-Lavrencic M, Salesse S, Delwel R, Verfaillie CM. 2005. BCR/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL-positive cells. Leukemia 19: 373-380.
18. Kieser JA, Groeneveld HT. 1994. Effects of prenatal exposure to tobacco smoke on developmental stability in children. J Craniofac Genet Dev Biol 14:43-47.
19. Kroll SL, Czyzyk-Krzeska MF. 1998. Role of H2O2 and heme-containing O2 sensors in hypoxic regulation of tyrosine hydroxylase gene expression. Am J Physiol 274:C167-C174.
20. Krous HF. 1981. Fetal alcohol syndrome: a dilemma of maternal alcoholism. Pathol Annu 16 Pt 1:295-311.
21. Li YB, Kaur C, Ling EA. 1998. Neuronal degeneration and microglial reaction in the fetal and postnatal rat brain after transient maternal hypoxia. Neurosci Res 32:137-148.
22. Lichtensteiger W, Schlumpf M. 1985. Prenatal nicotine affects fetal testosterone and sexual dimorphism of saccharin preference. Pharmacol Biochem Behav 23:439-444.
23. Lindahl E, Michelsson K, Helenius M, Parre M. 1988. Neonatal risk factors and later neurodevelopmental disturbances. Dev Med Child Neurol 30:571-589.
24. Mallard EC, Williams CE, Johnston BM, Gluckman PD. 1995. Neuronal damage in the developing brain following intrauterine asphyxia. Reprod Fertil Dev 7:647-653.
25. Mann LI. 1986. Pregnancy events and brain damage. Am J Obstet Gynecol 155:6-9.
26. Mayerhofer M, Valent P, Sperr WR, Griffin JD, Sillaber C. 2002. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 100:3767-3775.
27. McFarland BJ, Seidler FJ. Slotkin TA. 1991. Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. Brain Res Dev Brain Res 58:223-229.
28. McWhirter JR, Wang JY. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J 12:1533-1546.
29. Naeye RL, Peters EC. 1987. Antenatal hypoxia and low IQ values. Am J Dis Child 141:50-54.
30. Nafstad P, Fugelseth D, Qvigstad E, Zahlen K, Magnus P, Lindemann R. 1998. Nicotine concentration in the hair of nonsmoking mothers and size of offspring. Am J Public Health 88:120-124.
31. Nowakowski RS. 1991. Genetic disturbances of neuronal migration: some examples from the limbic system of mutant mice. In: Mednick SA, Cannon TD, Barr CE, Lyon M, editors. Fetal neural development and adult schizophrenia. New York: Cambridge University Press, p 69-96.
32. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB. 1996. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173-11178.
33. Papile LA. 1988. The management of hypoxic-ischemic encephalopathy. Pediatr Ann 17:524-526.
34. Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH. 1998. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem 273: 24057-24064.
35. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622.
36. Powers JM. 1995. The pathology of peroxisomal disorders with pathogenetic considerations. J Neuropathol Exp Neurol 54:710-719.
37. Ritchie K. 1980. The fetal response to changes in the composition of maternal inspired air in human pregnancy. Semin Perinatol 4: 295-299.
38. Romero RD, Chen WJ. 2004. Gender-related response in open-field activity following developmental nicotine exposure in rats. Pharmacol Biochem Behav 78:675-681.
39. Roy TS, Andrews JE, Seidler FJ, Slotkin TA. 1998. Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther 287:1136-1144.
40. Roy TS, Sabherwal U. 1994. Effects of prenatal nicotine exposure on the morphogenesis of somatosensory cortex. Neurotoxicol Teratol 16: 411-421.
41. Roy TS, Sabherwal U. 1998. Effects of gestational nicotine exposure on hippocampal morphology. Neurotoxicol Teratol 20:465-473.
42. Ryan RE, Ross SA, Drago J, Loiacono RE. 2001. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br J Pharmacol 132:1650-1656.
43. Schwartz JE, Kovach A, Meyer J, McConnell C, Iwamoto HS. 1998. Brief, intermittent hypoxia restricts fetal growth in Sprague-Dawley rats. Biol Neonate 73:313-319.
44. Slotkin TA, Greer N, Faust J, Cho H, Seidler FJ. 1986. Effects of maternal nicotine injections on brain development in the rat: ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions. Brain Res Bull 17:41-50.
45. Smith D. 2003. Cdk5 in neuroskeletal dynamics. Neurosignals 12: 239-251.
46. Socol ML, Manning FA, Murata Y, Druzin ML. 1982. Maternal smoking causes fetal hypoxia: experimental evidence. Am J Obstet Gynecol 142:214-218.
47. Stevens TR, Krueger SR, Fitzsimonds RM, Picciotto MR. 2003. Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J Neurosci 23:10093-10099.
48. Toison CM, Seidler FJ, McCook EC, Slotkin TA. 1995. Does concurrent or prior nicotine exposure interact with neonatal hypoxia to produce cardiac cell damage? Teratology 52:298-305.
49. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E. 1994. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423.
50. Tsai LH, Takahashi T, Caviness VS, Jr., Harlow E. 1993. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029-1040.
51. Uvebrant P, Hagberg G. 1992. Intrauterine growth in children with cerebral palsy. Acta Paediatr 81:407-412.
52. Van Etten RA. 1999. Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol 9:179-186.
53. Vartiainen N, Keksa-Goldsteine V, Goldsteins G, Koistinaho J. 2002. Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/reoxygenation damage in culture. J Neurochem 82:329-335.
54. Woodring PJ, Litwack ED, O'Leary DD, Lucero GR, Wang JY, Hunter T. 2002. Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J Cell Biol 156:879-892.
55. Zbuzek VK, Zbuzek V. 1999. Effect of pre- and postnatal nicotine exposure on vasopressinergic system in rats. Brain Res Dev Brain Res 112:229-235.
56. Zechel J, Gohil H, Lust WD, Cohen A. 2002. Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus. J Neurosci Res 69:662-668.
57. Zheng M, Leung CL, Liem RK. 1998. Region-specific expression of cyclin-dependent kinase 5 (cdkS) and its activators, p35 and p39, in the developing and adult rat central nervous system. J Neurobiol 35: 141-159.